• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童亚胺培南的肾脏清除率。

Renal clearance of imipenem in children.

作者信息

Jacobs R F, Kearns G L, Brown A L, Trang J M, Kluza R B

出版信息

Eur J Clin Microbiol. 1984 Oct;3(5):471-4. doi: 10.1007/BF02017378.

DOI:10.1007/BF02017378
PMID:6594236
Abstract

Imipenem renal clearance was studied in six children (three males, three females; 2.9-11.2 years of age) following a single intravenous dose (21.7 +/- 5.1 mg/kg) of imipenem/cilastatin (1:1). In an approximately six-hour period following drug administration, 65.3 +/- 9.7% of the imipenem dose was excreted in the urine unchanged. The renal clearance (280.03 +/- 24.34 ml/min/1.73 m2) of imipenem was found to account for 69.2% of the corresponding plasma imipenem clearance (404.89 +/- 24.83 ml/min/1.73 m2). Contrary to existing adult data, the imipenem renal clearance in our subjects was 1.95-fold greater than the estimated creatinine clearance, suggesting significant tubular secretion of imipenem in children. Examination of urinary imipenem excretion rate versus plasma concentration relationships in three of the children revealed a potential renal tubular reabsorption component for imipenem in children. Comparison of renal imipenem clearance data in these children to similar data from adults suggests that quantitatively important developmental differences may exist for the renal handling of imipenem.

摘要

在6名儿童(3名男性,3名女性;年龄2.9 - 11.2岁)单次静脉注射剂量为(21.7±5.1mg/kg)的亚胺培南/西司他丁(1:1)后,对亚胺培南的肾脏清除率进行了研究。在给药后的大约6小时内,65.3±9.7%的亚胺培南剂量以原形经尿液排出。发现亚胺培南的肾脏清除率(280.03±24.34ml/min/1.73m²)占相应血浆中亚胺培南清除率(404.89±24.83ml/min/1.73m²)的69.2%。与现有的成人数据相反,我们研究对象中亚胺培南的肾脏清除率比估计的肌酐清除率高1.95倍,这表明儿童中亚胺培南存在显著的肾小管分泌。对3名儿童尿液中亚胺培南排泄率与血浆浓度关系的检查显示,儿童中亚胺培南存在潜在的肾小管重吸收成分。将这些儿童中亚胺培南的肾脏清除率数据与成人的类似数据进行比较表明,在亚胺培南的肾脏处理方面可能存在重要的发育差异。

相似文献

1
Renal clearance of imipenem in children.儿童亚胺培南的肾脏清除率。
Eur J Clin Microbiol. 1984 Oct;3(5):471-4. doi: 10.1007/BF02017378.
2
Multiple-dose pharmacokinetics of imipenem-cilastatin.亚胺培南-西司他丁的多剂量药代动力学。
Antimicrob Agents Chemother. 1984 Nov;26(5):715-21. doi: 10.1128/AAC.26.5.715.
3
The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.亚胺培南(硫霉素-甲脒)和肾脏脱氢肽酶抑制剂西司他丁钠在正常受试者和肾衰竭患者中的药代动力学。
Br J Clin Pharmacol. 1984 Aug;18(2):183-93. doi: 10.1111/j.1365-2125.1984.tb02451.x.
4
Pharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure.
J Antimicrob Chemother. 1986 Dec;18 Suppl E:115-20. doi: 10.1093/jac/18.supplement_e.115.
5
Pharmacokinetics of imipenem and cilastatin in volunteers.
Rev Infect Dis. 1985 Jul-Aug;7 Suppl 3:S435-46. doi: 10.1093/clinids/7.supplement_3.s435.
6
Imipenem/cilastatin: pharmacokinetic profile in renal insufficiency.
Am J Med. 1985 Jun 7;78(6A):54-61. doi: 10.1016/0002-9343(85)90102-0.
7
Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients.
Pediatr Pharmacol (New York). 1986;5(4):273-9.
8
Disposition of radiolabeled imipenem and cilastatin in normal human volunteers.放射性标记亚胺培南与西司他丁在正常人类志愿者体内的处置情况。
Antimicrob Agents Chemother. 1984 Nov;26(5):707-14. doi: 10.1128/AAC.26.5.707.
9
An overview of the pharmacology of imipenem/cilastatin.
J Antimicrob Chemother. 1986 Dec;18 Suppl E:79-92. doi: 10.1093/jac/18.supplement_e.79.
10
The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers.在六名正常志愿者中,高剂量(1克)亚胺培南与1克西司他丁联合使用时的血浆药代动力学。
Eur J Clin Microbiol. 1984 Oct;3(5):468-70. doi: 10.1007/BF02017377.

引用本文的文献

1
Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.DMET 个体发育对新生儿和儿科重症监护病房常用药物处置的潜在影响。
Expert Opin Drug Metab Toxicol. 2021 Mar;17(3):273-289. doi: 10.1080/17425255.2021.1858051. Epub 2021 Jan 20.
2
Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings.儿童用药剂量:儿科药物研发和临床环境中药代动力学异速生长比例缩放及建模方法的批判性综述
Clin Pharmacokinet. 2014 Apr;53(4):327-46. doi: 10.1007/s40262-014-0134-5.
3

本文引用的文献

1
Pediatric clinical pharmacology of digoxin.
Pediatr Clin North Am. 1981 Feb;28(1):203-16. doi: 10.1016/s0031-3955(16)33971-2.
2
Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase.硫霉素及相关碳青霉烯类抗生素在肾脏二肽酶即脱氢肽酶作用下的代谢
Antimicrob Agents Chemother. 1982 Jul;22(1):62-70. doi: 10.1128/AAC.22.1.62.
3
Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications.新生儿和婴儿的临床药代动力学。年龄相关差异及治疗意义。
Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults.
儿科人群与成人之间药代动力学差异的因素和机制。
Pharmaceutics. 2011 Feb 7;3(1):53-72. doi: 10.3390/pharmaceutics3010053.
4
Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.乌干达坎帕拉儿童中蒿甲醚-本芴醇和青蒿琥酯-阿莫地喹的药代动力学。
Antimicrob Agents Chemother. 2010 Jan;54(1):52-9. doi: 10.1128/AAC.00679-09. Epub 2009 Oct 19.
5
Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.基于发育生理学和药代动力学考量的儿科用药剂量指南。
Clin Pharmacokinet. 2006;45(11):1077-97. doi: 10.2165/00003088-200645110-00003.
6
Clinical pharmacology: special safety considerations in drug development and pharmacovigilance.临床药理学:药物研发与药物警戒中的特殊安全性考量
Drug Saf. 2004;27(8):535-54. doi: 10.2165/00002018-200427080-00006.
7
Comparative pharmacokinetics of the carbapenems: clinical implications.碳青霉烯类药物的比较药代动力学:临床意义。
Clin Pharmacokinet. 2000 Sep;39(3):185-201. doi: 10.2165/00003088-200039030-00002.
8
Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.亚胺培南/西司他丁:其抗菌活性、药代动力学及治疗严重感染疗效的最新进展
Drugs. 1996 Jan;51(1):99-136. doi: 10.2165/00003495-199651010-00008.
9
Imipenem/cilastatin.亚胺培南/西司他丁
Eur J Clin Microbiol. 1984 Oct;3(5):453-5. doi: 10.1007/BF02017374.
10
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.亚胺培南/西司他丁。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001.
Clin Pharmacokinet. 1980 Nov-Dec;5(6):485-527. doi: 10.2165/00003088-198005060-00001.
4
Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.N-甲酰亚胺硫霉素对革兰氏阳性和革兰氏阴性需氧及厌氧菌的体外比较活性及其β-内酰胺酶稳定性
Antimicrob Agents Chemother. 1982 Jan;21(1):180-7. doi: 10.1128/AAC.21.1.180.
5
Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors.N-甲酰亚胺基硫霉素脱氢肽酶抑制剂共同给药对N-甲酰亚胺基硫霉素(MK0787)尿回收率的影响
Antimicrob Agents Chemother. 1983 Feb;23(2):300-7. doi: 10.1128/AAC.23.2.300.
6
Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.N-甲酰亚胺基硫霉素(MK0787)在人体中的药代动力学和耐受性。
Antimicrob Agents Chemother. 1983 Feb;23(2):293-9. doi: 10.1128/AAC.23.2.293.
7
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.N-甲脒基硫霉素(MK0787):与头孢噻肟、莫西沙星及其他β-内酰胺类抗生素相比的体外抗菌活性及对β-内酰胺酶的敏感性
J Antimicrob Chemother. 1981 Jun;7(6):607-17. doi: 10.1093/jac/7.6.607.
8
Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.通过静脉输注后获得的输注后血药浓度曲线评估药代动力学常数。
J Pharm Sci. 1970 Jan;59(1):53-5. doi: 10.1002/jps.2600590107.
9
A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.一种根据儿童身长和血肌酐得出的肾小球滤过率简易估算方法。
Pediatrics. 1976 Aug;58(2):259-63.
10
ESTRIP, a BASIC computer program for obtaining initial polyexponential parameter estimates.ESTRIP,一个用于获取初始多指数参数估计值的BASIC计算机程序。
J Pharm Sci. 1978 Dec;67(12):1687-91. doi: 10.1002/jps.2600671214.